immunized against pertussis are much more susceptible to infection by other gram negative bacteria than are their normal litter mates. Apparently, specific immunization can produce a non-specific lowering of resistance which predisposes the host to unrelated infections"5 and this may well be listed as another untoward effect of bacterial allergy.
Because bacterial protein has been shown to play a part in hypersensitivity and, from the above observation, is implicated in the etiology of infections, the search for an appropriate protein for desensitization was undertaken. The obvious selection was protein associated with the nucleic acid of the bacterial cell from the specific Henmophilus organism. Injection of this material reinforced the resistance of sensitized animals. However, since hypersensitivity is not species specific, the possibility of another source of comparable material was apparent and it was found that a commercial preparation of yeast sodium nucleate would not only reduce the hypersensitivity of vaccinated animals to the same pertussis antigen, but would make them refractory to gram negative bacteria. This logically lead to the possibility of protection for normal animals against similar infection.
Our numerous experiments prove that normal mice after injection with sodium nucleate are protected against infection by Proteus, Pasteurella, Brucella and E. coli organisms. Subsequent studies indicated that different brands of sodium nucleate were variable in potency; some were even inactive. Furthermore, the protective dosage of the active preparations ran as high as 100 mg./mouse. In search of the active principle we looked to the source material and undertook the fractionation of yeast. Although we did not identify the principle agent, we have succeeded in isolating a very potent fraction from a pressed cake of baker's yeast. Since the therapy of gram negative infections presents a persistent clinical problem, we have hastened to present these data in preliminary form. Details of the preparation and identification of the active material will be described later.
Briefly, it can be said that from 4 lbs. of yeast cake, 1.5 gm. of a dry material has been isolated which represents that particular yeast fraction Table 1 shows the effect of 100 mg. of sodium nucleate against infection by one of three different organisms, and Table 2 shows the comparable protection provided by the yeast fraction in Proteus infections of both mice and guinea pigs. From these data it is evident that commercial sodium nucleate in large doses and a new yeast preparation in small doses will protect animals against infection with gram negative bacteria. As far as we know yeast is 76 Volume 26, September 1953 not currently used in the preparation of antibiotics although seven years ago Sartory and Meyer' reported the in vitro inhibition of Proteus by yeast macerate. In our experiments we could not confirm these observations. Moreover, we have found that sodium nucleate has no in vitro bacteriocidal or bacteriostatic activity whatever. 
SUMMARY
Normal and sensitized mice are protected against the various gram negative bacteria tested by certain commercial preparations of sodium nucleate. In a search for a active component we have isolated from a pressed cake of baker's yeast a potent fraction which is over 300-fold more effective. Further work concerning the purification and identification of this yeast fraction is in progress.
